Abstract:Aminopeptidase N(APN/CD13) is an important zinc dependent metallo-exopeptidase,which is over expressed in tumor cells and plays a critical role in tumor invasion,metastasis and tumor angiogenesis.In order to find better aminopeptidase N inhibitors,One N-substituted-2,6-dioxopiperidin derivative(S)-2-amino-N-((S)-1-(2-(2-(dimethylamino)ethylamino)-2-oxoethyl)-2,6-dioxopiperidin-3-yl)-3-phenylpropanamide(8) was synthesized.Boc-L-glutamine(2) was synthesized from optical pure L-glutamine by protection with(Boc)2O and then cyclization in the presence of DCC and NHSu in THF.(S)-tert-butyl-2,6-dioxopiperidin-3-ylcarbamate(3),which was synthesized by alkylation of compound 2 with benzyl bromoacetate,was then treated with TFA to give compound 4.Then compound 4 was coupled with Boc-L-Phe to give compound 5,which was then catalytically hydrogenated using 10% Pd/C to afford compound 6.Coupling between compound 6 and N,N-dimethylpropan-1-amine in the presence of CDI gave compound 7.Compound 7 was finally treacted with HCl-EtOAc to give the target compound 8.The in vitro inhibitory activity of the target compound against APN was evaluated,and the IC50 value was 56.4 μmol · L-1(the IC50 value of the control Bestatin was 3.6 μmol · L-1).The result showed that the target compound had some activity while it need further modification to find better APN inhibitors.

Novel 3-Galloylamido-n′-substituted-2,6-piperidinedione-n-acetamide Peptidomimetics As Metalloproteinase Inhibitors

Design, Synthesis and Preliminary Activity Evaluation of Novel Peptidomimetics As Aminopeptidase N/CD13 Inhibitors

Design, Synthesis and Preliminary Evaluation of Α-Sulfonyl Γ-(Glycinyl-amino)proline Peptidomimetics As Matrix Metalloproteinase Inhibitors.

The Synthesis and Preliminary Activity Assay in Vitro of Peptide-Like Derivatives As APN Inhibitors

Design, Synthesis and Primary Activity Assay of Bi- or Tri-Peptide Analogues with the Scaffold L-Arginine As Amino-Peptidase N/CD13 Inhibitors

Novel Aminopeptidase N Inhibitors Derived from Antineoplaston AS2–5 (part I)

Novel Potent 2,5-Pyrrolidinedione Peptidomimetics As Aminopeptidase N Inhibitors. Design, Synthesis and Activity Evaluation

Design, Synthesis and Biological Evaluation of Novel 1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid Derivatives As Aminopeptidase N/CD13 Inhibitors.

Design,synthesis and Bioactivity Evalution of N-substituted-2,6-dioxopiperidin Derivatives As Aminopeptidase N(APN/CD13) Inhibitors

Design, Synthesis and Preliminary Evaluation of Novel Pyrrolidine Derivatives As Matrix Metalloproteinase Inhibitors

Novel Cyclic-Imide Peptidomimetics As Aminopeptidase N Inhibitors. Structure-Based Design, Chemistry and Activity Evaluation. Ii

Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).

Novel β-dicarbonyl derivatives as inhibitors of aminopeptidase N (APN).

Design, Synthesis and Sar Studies of Tripeptide Analogs with the Scaffold 3-Phenylpropane-1,2-diamine As Aminopeptidase N/Cd13 Inhibitors

Design, synthesis and preliminary activity evaluation of novel 3-amino-2-hydroxyl-3-phenylpropanoic acid derivatives as aminopeptidase N/CD13 inhibitors.

Novel 3-Phenylpropane-1,2-diamine Derivates As Inhibitors of Aminopeptidase N (APN).

Design, synthesis and biological evaluation of novel L-isoserine tripeptide derivatives as aminopeptidase N inhibitors.

Design, Synthesis, and Primary Activity Evaluation of Pyrrolidine Derivatives As Matrix Metalloproteinase Inhibitors.

Design, Synthesis, and QSAR Studies of Novel Lysine Derives As Amino-Peptidase N/CD13 Inhibitors.

Peptidomimetics and Metalloprotease Inhibitors As Anticancer Drugs

Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.